Xiaoying Mai
GF Xinde
Investment directorDr. Manoj Manoj
ISHA Therapeutics LLC
Founder and CEOMr. Estigarribia Marc
MSQ Ventures
MDMr. Richard McCrae
Kymeris therapeutics Inc
President & CEOMichael McNeely
GattaCo develops products that enable fast accurate evidence-based decision making to improve healthcare outcomes. We do this by solving the fundamental problems in sample purification, the most challenging component of the diagnostic testing workflow.
Our new Plasm™ Module is a revolutionary, patented, automatic plasma separation and metering module or insert used to provide high-purity, metered plasma to a rapid diagnostic testing platform, such as lateral flow, biosensor, or other Point of Care (POC) device, from finger-stick capillary blood. The initial version of the Plasm Module is optimized for antibody testing and will revolutionize POC diagnostics by improving:
- Sensitivity: Increased number of antibodies compared to the same volume of whole blood.
- Specificity Accuracy: High quality/purity sample with reduced background.
- Repeatability: Plasma is metered to +/- 5%. Quantitation: Precisely metered output, independent of hematocrit.
GATTACO Inc.
Pres/CEOMiss Yifan Meng
苏州工业园区生物产业发展有限公司
SpeciallistMr. Sam Meredith
Who We Are
An executive search and talent acquisition specialist with a wealth of experience in the life science business sector
An alternative to the generalist search firms that offer only general search services
Able to find the right talent for you with the right approach and understanding the complexity of the life science industry
Able to build pools helping our clients to attract a long term and sustainable talent pipeline for current and future requirements, placing your company ahead of competition
Bioprogress
Vice PresidentDr. Doreen Miao
Ananda Devices is a biotech company specialized in in vitro assay developments. Leveraging our proprietary nano-organization technology, we have developed physiologically relevant in vitro models that generate predicative responses early on in the compound development processes, thereby accelerating compound discovery and de-risking key developmental investments.
Our nervous on-a-chip technology enables clients to perform drug screening, toxicity and efficacy testing up to 50x faster and 90% more cost-effective. We have 20+ years of experience in neuroscience and tissue engineering, and we have been a developer of unique devices to grow brain, spinal cord and innervated skin models for clients in 12 countries.
Our product:
NeuroHTSTM is a first-in-class high throughput screening (HTS) platform to rapidly cultivate over 3,000 CNS or PNS neurons/plate into physiologically relevant networks.
Its easy-to-use technology requires no additional equipment such as shakers and tubing.
It is compatible with most automation solutions, suitable for both and human/animal models
Our customized services:
Our core technology enables 4 types of innovative assay developments:
-Organization of cell and tissue types for reproducible and physiologically relevant in vitro testing
-Innervation of different tissues
-Miniaturization of existing models to increase throughput and sensitivity
-Development of complex co-culture models to mimic disease on-a-chip